Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin
出版年份 2013 全文链接
标题
Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin
作者
关键词
-
出版物
ONCOGENE
Volume 33, Issue 19, Pages 2441-2453
出版商
Springer Nature
发表日期
2013-06-17
DOI
10.1038/onc.2013.220
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- The extracellular matrix: A dynamic niche in cancer progression
- (2012) Pengfei Lu et al. JOURNAL OF CELL BIOLOGY
- RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis
- (2012) Min Yu et al. NATURE
- BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours
- (2011) V.L. Bock et al. BRITISH JOURNAL OF DERMATOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategy
- (2011) S Gramling et al. ONCOGENE
- Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk
- (2011) G Liu et al. ONCOGENE
- Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner
- (2010) Neta Erez et al. CANCER CELL
- Breast Cancer Cells in Three-dimensional Culture Display an Enhanced Radioresponse after Coordinate Targeting of Integrin 5 1 and Fibronectin
- (2010) J.-M. Nam et al. CANCER RESEARCH
- ErbB2 requires integrin 5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells
- (2010) K. K. Haenssen et al. JOURNAL OF CELL SCIENCE
- HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype
- (2010) Penney M. Gilbert et al. JOURNAL OF CLINICAL INVESTIGATION
- Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation
- (2010) Rebecca Lock et al. MOLECULAR BIOLOGY OF THE CELL
- Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer
- (2010) Anne-Marie C Dingemans et al. Molecular Cancer
- Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes
- (2010) S Tabariès et al. ONCOGENE
- 1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression
- (2010) L. Huck et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
- (2009) Kandice R. Levental et al. CELL
- RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
- (2009) Scott Valastyan et al. CELL
- Regulation of 4-integrin expression by epigenetic modifications in the mammary gland and during the epithelial-to-mesenchymal transition
- (2009) X. Yang et al. JOURNAL OF CELL SCIENCE
- The SWI/SNF complex and cancer
- (2009) D Reisman et al. ONCOGENE
- Mammary Epithelial-Specific Disruption of Focal Adhesion Kinase Retards Tumor Formation and Metastasis in a Transgenic Mouse Model of Human Breast Cancer
- (2008) Paolo P. Provenzano et al. AMERICAN JOURNAL OF PATHOLOGY
- Fibronectin Expression Modulates Mammary Epithelial Cell Proliferation during Acinar Differentiation
- (2008) C. M. Williams et al. CANCER RESEARCH
- The SWI/SNF ATPase Brm Is a Gatekeeper of Proliferative Control in Prostate Cancer
- (2008) H. Shen et al. CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started